QR код

Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

BackgroundPathological response to neoadjuvant treatment for patients with high-grade serous ovarian carcinoma (HGSOC) is assessed using the chemotherapy response score (CRS) for omental tumor deposits. The main limitation of CRS is that it requires surgical sampling after initial neoadjuvant chemot...

Повний опис

Збережено в:
Автори: Leonardo Rundo, Lucian Beer, Lorena Escudero Sanchez, Mireia Crispin-Ortuzar, Marika Reinius, Cathal McCague, Hilal Sahin, Vlad Bura, Roxana Pintican, Marta Zerunian, Stephan Ursprung, Iris Allajbeu, Helen Addley, Paula Martin-Gonzalez, Thomas Buddenkotte, Naveena Singh, Anju Sahdev, Ionut-Gabriel Funingana, Mercedes Jimenez-Linan, Florian Markowetz, James D. Brenton, Evis Sala, Ramona Woitek
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2022-06-01
Серія:Frontiers in Oncology
Предмети:
ovarian cancer
radiomics
computed tomography
chemotherapy response score
neoadjuvant chemotherapy
Онлайн доступ:https://www.frontiersin.org/articles/10.3389/fonc.2022.868265/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси